$33.030
-2.187 (-6.62%)終値時点
ALGM のニュース
ALGM のイベント
Allegro Sees Q3 Revenue of $278M-$288M
Sees Q3 revenue $278M-$288M, consensus $276.76M. Sees Q3 operating expenses $87M +/- $1M. "During the quarter, we also continued to execute on our strategic priorities of expanding profitability and generating strong cash flow," said Derek D'Antilio, Executive Vice President and CFO of Allegro. "On September 30, 2026, following the close of the second quarter, we made another $25 million voluntary debt repayment, underscoring the strength of our balance sheet and our confidence in Allegro's anticipated free cash flow generation."
Allegro Q2 Revenue Reaches $276.88M, Beating Expectations
Reports Q2 revenue $276.88M, consensus $270.87M. "We saw continued strong momentum in our fiscal second quarter, delivering our seventh consecutive quarter of sequential sales growth. Sales were $277 million, representing a 29% increase year-over-year. GAAP earnings per share quadrupled from $0.03 per share in the fiscal second quarter of 2026 to $0.12. Non-GAAP EPS grew to $0.26, doubling over the second quarter of fiscal 2026. Broad year-over-year sales growth in Automotive and Industrial end markets drove this strong performance, led by data center, which established a new record," said Mike Doogue, President and CEO of Allegro. "Our forward demand signals strengthened significantly this quarter. We delivered our highest quarterly design-win performance since our 2020 IPO-up nearly 40% year-over-year-and bookings increased for the eighth consecutive quarter. With record design wins, a robust backlog, and expanding content across our target Automotive and Industrial markets, the leading indicators across our business give us high confidence in our path to exceed our target model of mid-teens annual sales growth."
Sees Q2 Revenue of $265M-$275M
Sees Q2 revenue $265M-$275M, consensus $263.82M.
Sera Prognostics Joins $10.4M ARPA-H Research Program
Sera Prognostics (SERA) announced its participation in a multi-institutional research program that was awarded up to $10.4M by the Advanced Research Projects Agency for Health, or ARPA-H, to develop a novel point-of-care diagnostic test designed to improve the safety of labor and delivery. The award, part of ARPA-H's Making Obstetrics Care Smart program, supports a collaboration led by researchers at the University of California San Diego alongside Sera Prognostics and Allegro MicroSystems (ALGM). The program aims to develop new technologies that enable more precise, data-driven decision-making during childbirth. The research team is working to develop a diagnostic approach that can assess the risk of low fetal oxygen levels from a small maternal blood sample. The program will explore the integration of identified biomarkers into a rapid, point-of-care testing platform capable of delivering results from a small maternal blood sample.
Allegro MicroSystems Appoints Brian White as Independent Director
Allegro MicroSystems announced the appointment of Brian White to Allegro's Board of Directors as an independent director. White's appointment was effective on June 17, 2026.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。







